The CHCT involves a muscle biopsy, usually taken from the quadriceps. The muscle sample is then exposed to caffeine and halothane in a controlled laboratory setting. The test measures the contracture (or tightening) response of the muscle to these agents. An abnormal response indicates susceptibility to MH.
